Testicular Cancer
📧 Sign up to get email alerts when something new happens for Testicular Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-06-25Clinical Trial Update: CLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid Tumors [Phase 1]
A phase 1 trial evaluating CLDN6/GPC3/Mesothelin/AXL-CAR-NK cell therapy for advanced solid tumors is currently recruiting, including stage …
-
CLINICAL_TRIALS trial_result · 2024-05-17Clinical Trial Update: Vascular Fingerprint Validation Study
The University Medical Center Groningen reports that the Vascular Fingerprint Validation Study for testicular cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Mental Health of Men Before and After Testicular Cancer Treatment
The study completed its evaluation of mental health outcomes in men with testicular cancer before and after treatment, including cognitive f…
-
FDA approval · 2024-05-10FDA Approved: CISPLATIN — Original Application (Apotex Corp.)
FDA approved the original application for cisplatin from Apotex Corp., enabling the generic version to be marketed in the United States.
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Knowledge and Attitudes Regarding Healthy Lifestyle and Health Behavior Change in Cancer Patients and Their Partners; A Pilot Study
A completed pilot clinical trial evaluating knowledge and attitudes toward healthy lifestyle and health behavior change among cancer patient…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: Cardiovascular Morbidity in Testicular Cancer Survivors: Study of Risk Factors and Assessment of Pharmacogenomic Determinants of Toxicity
This completed clinical trial investigates cardiovascular morbidity risk factors and pharmacogenomic determinants of toxicity in survivors o…
-
CLINICAL_TRIALS other · 2024-05-01Clinical Trial Update: The Man Van Project [NA]
The Man Van Project clinical trial, sponsored by Royal Marsden NHS Foundation Trust, is currently recruiting for prostate cancer and related…
-
CLINICAL_TRIALS research · 2024-04-29Clinical Trial Update: Study on the Quality of Life and Functional/Oncological Outcome of Testicular Cancer Patients
A clinical trial, sponsored by IRCCS San Raffaele, is currently recruiting to assess quality of life and functional/oncological outcomes in …
-
CLINICAL_TRIALS trial_result · 2024-04-19Clinical Trial Update: Taste, Smell and Chemotherapy (TASTY) [Phase 4]
Phase 4 clinical trial update for the TASTY study evaluating taste and smell changes with chemotherapy in testicular cancer.
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Safety and Efficacy of FalateScan (Technetium Tc 99m EC20) in Patients With Known Suspected Recurrent or Metastatic Cancer From a Solid Tumor [Phase 2]
Phase 2 clinical trial evaluating FalateScan (Technetium Tc 99m EC20) for safety and efficacy in patients with suspected recurrent or metast…
-
CLINICAL_TRIALS trial_result · 2023-02-06Clinical Trial Update: Olanzapine Combined With Fosaprepitant, Ondansetron, and Dexamethasone for Preventing Nausea and Vomiting in Patients With Testicular Cancer [Phase 3]
A Phase 3 trial evaluating the addition of olanzapine to fosaprepitant, ondansetron, and dexamethasone for preventing chemotherapy-induced n…
-
CLINICAL_TRIALS trial_result · 2022-12-02Clinical Trial Update: A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers [Phase 1, Phase 2]
Phase 1/2 trial evaluating tremelimumab and IV durvalumab with Poly-ICLC in biopsy-accessible cancers; completed with results posted in 2022…
-
CLINICAL_TRIALS trial_result · 2021-03-03Clinical Trial Update: Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell Cancer [Phase 2]
Phase 2 trial update evaluating gemcitabine, carboplatin, and veliparib (ABT-888) in refractory testicular germ cell cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: A Biobehavioral Intervention for Young Men With Testicular Cancer [Phase 2]
Phase 2 clinical trial updating a biobehavioral intervention for young men with testicular cancer.
-
CLINICAL_TRIALS trial_result · 2020-03-06Clinical Trial Update: Study of Testosterone vs Placebo in Testicular Cancer Survivors [Phase 2, Phase 3]
Phase 2/3 trial comparing testosterone versus placebo in testicular cancer survivors, with focus on metabolic syndrome and Leydig cell failu…
-
CLINICAL_TRIALS trial_result · 2019-11-26Clinical Trial Update: Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors [Phase 2]
Phase 2 trial of brentuximab vedotin in relapsed/refractory germ cell tumors was terminated; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-01-25Clinical Trial Update: Carboplatin AUC-10 With Early PET Scanning in Metastatic Seminoma [Phase 2]
Phase 2 trial evaluating carboplatin AUC-10 with early PET scanning in metastatic seminoma has completed and results are posted.
-
CLINICAL_TRIALS withdrawal · 2018-02-28Clinical Trial Update: Establishing of Neuronal-like Cells From Patients With Cisplatin-Induced Peripheral Neuropathy
The clinical trial NCT02492360 that aimed to establish neuronal-like cells from patients with cisplatin-induced peripheral neuropathy has be…
-
CLINICAL_TRIALS trial_result · 2017-10-17Clinical Trial Update: Quality of Life Among Testicular Cancer Survivors
An update on a clinical trial assessing quality of life in testicular cancer survivors; no specific results or status details are provided i…
-
CLINICAL_TRIALS research · 2017-08-25Clinical Trial Update: Epigenetic Integrity of Spermatozoa in Patients With Germinal Testicular Tumours
A clinical trial update investigates the epigenetic integrity of sperm in patients with germinal testicular tumors (seminomas); the trial st…
-
CLINICAL_TRIALS trial_result · 2017-07-07Clinical Trial Update: Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma [Phase 2]
Phase 2 study evaluating the combination of gemcitabine, oxaliplatin, and paclitaxel in patients with refractory germ cell carcinoma (testic…
-
FDA approval · 2017-03-17FDA Approved: CISPLATIN — Original Application (Sagent Pharmaceuticals)
FDA approved Sagent Pharmaceuticals' original application for cisplatin, a generic injectable chemotherapy agent (ANDA approval).
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors [Phase 2]
A Phase 2 clinical trial evaluated alvocidib plus oxaliplatin with or without fluorouracil and leucovorin calcium in relapsed or refractory …
-
CLINICAL_TRIALS research · 2017-01-26Clinical Trial Update: Testicular Cancer and Aerobic and Strength Training [NA]
terminated clinical trial from Oslo University Hospital evaluating aerobic and strength training in individuals with testicular cancer.
-
FDA approval · 2017-01-19FDA Approved: CISPLATIN — Supplemental Application (WG Critical Care, LLC)
The FDA approved a supplemental application for cisplatin submitted by WG Critical Care, LLC.